Calcium antagonist drugs are efficacious in the management of many cardiovascular diseases including coronary artery disease, cardiac arrhythmias, and hypertension. Since their release in the U.S., they have become among the most commonly prescribed cardiovascular drugs. There are both potential advantages and disadvantages of the use of these drugs over other available drugs (such as the beta-adrenergic receptor blocking drugs) in the ever-expanding population of geriatric patients. However, the clinical profile of these drugs in the elderly is currently unknown since premarketing metabolic and efficacy trials excluded the geriatric group. Pilot studies with calcium antagonist drugs in man suggest differences in both pharmacokinetic and pharmacodynamic responses between elderly and young hypertensive men. For this reason, it is proposed that there is both altered metabolism of the calcium antagonist drugs in the elderly and altered responses of the slow calcium channel-mediated activities of the sinus and atrioventricular nodes with aging.
The aims of this proposal are to determine the pharmacokinetics of three major calcium antagonists in physiologically aged individuals and elderly hypertensive patients and, contrast these parameters to data from young and middle-aged healthy and hypertensive individuals. Pharmacodynamic responses of the sinus node, atrioventricular node and blood pressure will also be studied in man and related to the altered kinetics of the calcium antagonists as will responses to parasympathetically-mediated and sympathetically-mediated stimuli during Ca++ antagonist infusions. The role of autonomic activity in the responses seen will also be evaluated by performing calcium antagonist infusion experiments in the presence and absence of autonomic blockade in the adult and senescent beagle. Elimination of systemic effects will be achieved by experiments: (1) with direct SA + AV nodal infusions of the drugs in dogs and, (2) by concentration-response studies in nonworking spontaneously beating right atrial preparations and in isolated perfused hearts from adult and senescent animals. The results of the proposed studies will provide important information regarding the metabolism and proper dosing of these drugs in the elderly and data regarding the altered sinus and AV nodal response profiles in the elderly. The studies will also explore the mechanisms underlying age-related differences in responses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG005940-02
Application #
3116663
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1986-08-01
Project End
1990-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Schwartz, J B (1996) Calcium antagonists in the elderly. A risk-benefit analysis. Drugs Aging 9:24-36
Craft, N; Schwartz, J B (1995) Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol 268:H1441-52
Harris, R Z; Benet, L Z; Schwartz, J B (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222-39
Schwartz, J B; Shen, C; Garcia, J et al. (1995) Influence of autonomic blockade and aging on AV conduction and responses to verapamil in the beagle. J Gerontol A Biol Sci Med Sci 50:M83-90
Schwartz, J B; Capili, H; Daugherty, J (1994) Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 55:509-17
Kusumoto, F M; Lurie, K G; Dutton, J et al. (1994) Effects of aging on AV nodal and ventricular beta-adrenergic receptors in the Fischer 344 rat. Am J Physiol 266:H1408-15
Schwartz, J B; Capili, H; Wainer, I W (1994) Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers. Clin Pharmacol Ther 56:368-76
Schwartz, J B; Caputo, G; Abbott, J (1993) Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS. J Am Geriatr Soc 41:967-74
Schwartz, J B; Troconiz, I F; Verotta, D et al. (1993) Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. J Pharmacol Exp Ther 265:690-8
Schrader, R; Brooks, M; Echt, D S (1992) Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs. J Cardiovasc Pharmacol 19:839-50

Showing the most recent 10 out of 16 publications